Literature DB >> 10631324

CROP/Luc7A, a novel serine/arginine-rich nuclear protein, isolated from cisplatin-resistant cell line.

Y Nishii1, M Morishima, Y Kakehi, K Umehara, N Kioka, Y Terano, T Amachi, K Ueda.   

Abstract

A novel putative SR protein, designated cisplatin resistance-associated overexpressed protein (CROP), has been cloned from cisplatin-resistant cell lines by differential display. The N-half of the deduced amino acid sequence of 432 amino acids of CROP contains cysteine/histidine motifs and leucine zipper-like repeats. The C-half consists mostly of charged and polar amino acids: arginine (58 residues or 25%), glutamate (36 residues or 16%), serine (35 residues or 15%), lysine (30 residues, 13%), and aspartate (20 residues or 9%). The C-half is extremely hydrophilic and comprises domains rich in lysine and glutamate residues, rich in alternating arginine and glutamate residues, and rich in arginine and serine residues. The arginine/serine-rich domain is dominated by a series of 8 amino acid imperfect repetitive motif (consensus sequence, Ser-Arg-Ser-Arg-Asp/Glu-Arg-Arg-Arg), which has been found in RNA splicing factors. The RNase protection assay and Western blotting analysis indicate that the expression of CROP is about 2-3-fold higher in mRNA and protein levels in cisplatin-resistant ACHN/CDDP cells than in host ACHN cells. CROP is the human homologue of yeast Luc7p, which is supposed to be involved in 5'-splice site recognition and is essential for vegetative growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10631324     DOI: 10.1016/s0014-5793(99)01744-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

Review 2.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  RBM25/LUC7L3 function in cardiac sodium channel splicing regulation of human heart failure.

Authors:  Ge Gao; Samuel C Dudley
Journal:  Trends Cardiovasc Med       Date:  2012-08-31       Impact factor: 6.677

4.  Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure.

Authors:  Ge Gao; An Xie; Shu-Ching Huang; Anyu Zhou; Jianhua Zhang; Amanda M Herman; Sassan Ghassemzadeh; Euy-Myoung Jeong; Srinivasan Kasturirangan; Mihai Raicu; Michael A Sobieski; Geetha Bhat; Antone Tatooles; Edward J Benz; Timothy J Kamp; Samuel C Dudley
Journal:  Circulation       Date:  2011-08-22       Impact factor: 29.690

5.  Splicing factors differentially expressed in psoriasis alter mRNA maturation of disease-associated EDA+ fibronectin.

Authors:  E Szlavicz; K Szabo; G Groma; Z Bata-Csorgo; F Pagani; L Kemeny; M Szell
Journal:  Mol Cell Biochem       Date:  2017-06-06       Impact factor: 3.396

6.  Proteomic snapshot of breast cancer cell cycle: G1/S transition point.

Authors:  Milagros J Tenga; Iulia M Lazar
Journal:  Proteomics       Date:  2013-01       Impact factor: 3.984

7.  Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo.

Authors:  Eiji Sakashita; Sawako Tatsumi; Dieter Werner; Hitoshi Endo; Akila Mayeda
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  A novel SR-related protein is required for the second step of Pre-mRNA splicing.

Authors:  Demian Cazalla; Kathryn Newton; Javier F Cáceres
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

9.  Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma.

Authors:  Adel M Zaatar; Chun Ren Lim; Chin Wei Bong; Michelle Mei Lin Lee; Jian Jiek Ooi; David Suria; Rakesh Raman; Samuel Chao; Hengxuan Yang; Soon Bin Neoh; Choong-Chin Liew
Journal:  J Exp Clin Cancer Res       Date:  2012-09-17

10.  Binding specificity of Toll-like receptor cytoplasmic domains.

Authors:  Victoria Brown; Rachel A Brown; Adrian Ozinsky; Jay R Hesselberth; Stanley Fields
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.